The role of the BRAF/ERK pathway on CD70 expression in melanoma cells was also investigated here because this pathway is essential in melanoma progression and metastasis [4], and because pharmacological inhibitors have a strong but often transitory efficacy against these tumors. Here, BRAF is linked to melanoma.